Aberrant promoter CpG islands methylation of tumor suppressor genes in cholangiocarcinoma

Oncology Research

Volumn 17, Issue 4, 2008, Pages 151-157

  Uhm, Kyung Ok ^a   Lee, Eun Soo ^a   Lee, Yun Mi ^a   Kim, Hyeon Soo ^a   Park, Young Nyun ^b   Park, Sun Hwa ^a  

^a Korea University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Cholangiocarcinoma; Hypermethylation; Methylation specific PCR; Tumor suppressor gene

Indexed keywords

DELETED IN LIVER CANCER PROTEIN; INHIBITOR OF DIFFERENTIATION 4; SECRETED FRIZZLED RELATED PROTEIN 1; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER INHIBITION; CARCINOGENESIS; CELL LINE; CHROMOSOME ABERRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENE INACTIVATION; GENE LOCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; TISSUE SPECIFICITY; TRANSCRIPTION INITIATION; TUMOR SUPPRESSOR GENE;

EID: 51049089912     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504008785114110     Document Type: Article

References (28)

1. Gao, Y.; Guan, M.; Su, B.; Liu, W.; Xu, M.; Lu, Y. Hypermethylation of the RASSF1A gene in gliomas. Clin, Chim. Acta 349:173-179; 2004.
2. Maruyama, R.; Sugio, K.; Yoshino, I.; Maehara, Y.; Gazdar, A. F. Hypermethylation of FHIT as a prognostic marker in non small cell lung carcinoma. Cancer 100: 1472-1477; 2004.
3. Baylin, S. B.; Herman, J. G. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 16:168-174; 2000.
4. Goel, A.; Arnold, C. N.; Tassone, P.; Chang, D. K.; Niedzwiecki, D.; Dowell, J. M.; Wasserman, L.; Compton, C.; Mayer, R. J.; Bertagnolli, M.M.; Boland, C. R. Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers. Int. J. Cancer 112:754-759; 2004.
5. Lindsey, J. C.; Lusher, M. E.; Strathdee, G.; Brown, R.; Gilbertson, R. J.; Baile, S.; Ellison, D. W.; Clifford, S. C. Epigenetic inactivation of MCJ (DNAJD1) in malignant paediatric brain tumours. Int. J. Cancer 118:346-352; 2006.
6. Tannapfel, A.; Benicke, M.; Katalinic, A.; Uhlmann, D.; Kockerling, F.; Hauss, J.; Wittekind, C. Frequency of p16(INK4A) alterations and K-ras mutations in intrahepatic cholangiocarcinoma of the liver. Gut 47:721-727; 2000.
7. Tannapfel, A.; Sommerer, F.; Benicke, M.; Weinans, L.; Katalinic, A.; Geissler, F.; Uhlmann, D.; Hauss, J.; Wittekind, C. Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma. J. Pathol. 197:624-631; 2002.
8. Lee, S.; Kim, W. H.; Jung, H. Y.; Yang, M. H.; Kang, G. H. Aberrant CpG island methylation of multiple genes in intrahepatic cholangiocarcinoma. Am. J. Pathol. 161: 1015-1022; 2002.
9. Yang, B.; House, M. G.; Guo, M.; Herman, J. G.; Clark, D. P. Promoter methylation profiles of tumor suppressor genes in intrahepatic and extrahepatic cholangiocarcinoma. Mod. Pathol. 18:412-420; 2005.
10. Roth, S.; Laiho, P.; Salovaara, R.; Launonen, V.; Aaltonen, L. A. No SMAD4 hypermethylation in colorectal cancer. Br. J. Cancer 83:1015-1019; 2000.
11. Uhm, K. O.; Park, Y. N.; Lee, J. Y.; Yoon, D. S.; Park, S. H. Chromosomal imbalances in Korean intrahepatic cholangiocarcinoma by comparative genomic hybridization. Cancer Genet. Cytogenet. 157:37-41; 2005.
12. Huang, J.; Zhang, Y. L..; Teng, X. M.; Lin, Y.; Zheng, D. L.; Yang, P. Y.; Han, Z. G. Down-regulation of SFRP1 as a putative tumor suppressor gene can contribute to human hepatocellular carcinoma. BMC Cancer 12(7):126; 2007.
13. Kim, T. Y.; Jong, H. S.; Song, S. H.; Dimtchev, A.; Jeong, S. J.; Lee, J. W.; Kim, T. Y.; Kim, N. K.; Jung, M.; Bang, T. J. Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells. Oncogene 22:3943-3951; 2003.
14. Lo, P. K.; Mehrotra,J.; D'Costa, A.; Fackler, M. J.; Garrett-Mayer, E.; Argani, P.; Sukumar, S. Epigenetic suppression of secreted frizzled related protein 1 (SFRP1) expression in human breast cancer. Cancer Biol. Ther. 5(3): 281-286; 2006.
15. Peng, D.; Ren, C. P.; Yi, H. M.; Zhou, L.; Yang, X. Y.; Li, H.; Yao, K. T. Genetic and epigenetic alterations of DLC-1, a candidate tumor suppressor gene, in nasopharyngeal carcinoma. Acta Biochim. Biophys. Sin. (Shanghai) 38(5):349-355; 2006.
16. Shih, Y. L.; Shyu, R. Y.; Hsieh, C. B.; Lai, H. C.; Liu, K. Y.; Chu, T. Y.; Lin YW. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma. Cancer 107:579-590; 2006.
17. Yuan, B. Z.; Jefferson, A. M.; Baldwin. K. T.; Thorgeirsson, S. S.; Popescu, N. C.; Reynolds, S. H. DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas. Oncogene 23(7):1405-1411; 2004.
18. Yu, L.; Liu, C.; Vandeusen, J.; Becknell, B.; Dai, Z.; Wu, Y. Z.; Raval, A.; Liu, T. H.; Ding, W.; Mao, C.; Liu, S.; Smith, L. T.; Lee, S.; Rassenti, L.; Marcucci, G.; Byrd, J.; Caligiuri, M. A.; Plass, C. Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia. Nat. Genet. 37(3):265-274; 2005.
19. Umetani, N.; Takeuchi, H.; Fujimoto, A.; Shinozaki, M.; Bilchik, A. J.; Hoon, D. S. Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis. Clin. Cancer Res. 10(22): 7475-7483; 2004.
20. Hagiwara, K.; Nagai, H.; Li, Y.; Ohashi, H.; Hotta, T.; Saito, H. Frequent DNA methylation but not mutation of the ID4 gene in malignant lymphoma. J. Clin. Exp. Hematop. 47(1):15-18; 2007.
21. Chan, A. S.; Tsui, W. Y.; Chen, X.; Chu, K. M.; Chan, T. L.; Chan, A. S.; Li, R.; So, S.; Yuen, S. T.; Leung, S. Y. Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma. Oncogene 22:6946-6953; 2003.
22. Kim, D. G.; Park, S. Y.; You, K. R.; Lee, G. B.; Kim, H.; Moon, W. S.; Chun, Y. H.; Park, S. H. Establishment and characterization of chromosomal aberrations in human cholangiocarcinoma cell lines by cross-species color banding. Genes Chromosomes Cancer 30:48-56; 2001.
23. Herman, J. G.; Graff, J. R.; Myohanen, S.; Nelkin, B. D.; Baylin, S. B. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 93:9821-9826; 1996.
24. Fort, P.; Marty, L.; Piechaczyk, M.; Sabrouty, S.; Dani, C.; Jeanteur, P.; Blanchard, J. M. Various rat adult tissues express only one major mRNA species from the glyceral-dehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 11:1431-1442; 1985.
25. Zhang, P.; Bhakta, K. S.; Puri, .P. L.; Newbury, R. O.; Feramisco, J. R.; Wang, J. Y. Association of ataxia telangiectasia mutated (ATM) gene mutation/deletion with rhabdomyosarcoma. Cancer Biol. Ther. 2:87-91; 2003.
26. Wong, C. M.; Lee, J. M.; Ching, Y. P.; Jin, D. Y.; Ng, I. O. Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma. Cancer Res. 15:7646-7651; 2003.
27. Xu, Y.; Ashley, T.; Brainerd, E. E.; Bronson, R. T.; Meyn, M. S.; Baltimore, D. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev. 10:2411-2422; 1996.
28. Carter, S. L.; Negrini, M.; Baffa, R.; Gillum, D. R.; Rosenberg, A. L.; Schwartz, G. F.; Croce, C. M. Loss of heterozygosity at 11q22-q23 in breast cancer. Cancer Res. 54:6270-6274; 1994.